Eric Curtis's most recent trade in Windtree Therapeutics Inc was a trade of 22,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 23, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Windtree Therapeutics Inc | Eric Curtis | SVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 22,000 | 22,000 | - | - | Employee Stock Option (Right to Buy) | |
| Windtree Therapeutics Inc | Eric Curtis | SVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 14,667 | 15,920 (0%) | 0% | 0 | Common Stock | |
| Windtree Therapeutics Inc | Eric Curtis | SVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 28 Feb 2023 | 99 | 1,253 (0%) | 0% | 0 | Common Stock | |
| Windtree Therapeutics Inc | Eric Curtis | SVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 99,600 | 99,600 | - | - | Employee Stock Option (Right to Buy) | |
| Windtree Therapeutics Inc | Eric Curtis | SVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 66,300 | 67,591 (0%) | 0% | 0 | Common Stock |